NEUROLEPTICS

Clinical trials for NEUROLEPTICS explained in plain language.

Never miss a new study

Get alerted when new NEUROLEPTICS trials appear

Sign up with your email to follow new studies for NEUROLEPTICS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for agitated cancer patients: drug combo tested to ease delirium

Symptom relief Recruiting now

This study tests four treatments—haloperidol, chlorpromazine, valproic acid, and a placebo—given through an IV to help calm agitated delirium in hospitalized cancer patients. The goal is to find which option works best to reduce distress and improve comfort. About 42 adults with …

Matched conditions: NEUROLEPTICS

Phase: PHASE2, PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief

Last updated Jun 27, 2026 07:58 UTC

NEUROLEPTICS

Get alerted when new NEUROLEPTICS trials appear

New hope for agitated cancer patients: drug combo tested to ease delirium